Summary
- Profile Type
- Technology offer
- POD Reference
- TORO20230313014
- Term of Validity
- 14 March 2023 - 13 March 2025
- Company's Country
- Romania
- Type of partnership
- Research and development cooperation agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
-
Romanian start-up develops AI-based software for optimizing radiotherapy procedures. Their software atomizes one of the most tedious and time-consuming processes of radiotherapy - the contouring of organs at risk. Using the software, the contouring is done in 5 minutes, maintaining a high level of accuracy.
They are interested in finding partners for product testing and for distributors in the medical field. - Full Description
-
The provider is a start-up company based in Romania, specialised in the development of software based on artificial intelligence for automation and improvement of imaging processes in the medical field. They have chosen Artificial Intelligence capabilities as it was proven to be much more impactful in innovative solutions.
The solution developed by the Romanian start-up is able to accurately identify and delineate cancerous tumours, organs at risk and target volumes for all areas, the contouring helping doctors to precisely distribute dose volumes of radiation.
The product has a friendly user interface with different adjustment tools and options adapted to doctors’ needs. Moreover, the platform can be both on-premises and cloud-based, with users being able to store the data inside their facility or access it easily from anywhere at any time. The patient’s dossier could be shared between any user, enhancing the communication, collaboration, and planning of the radiotherapeutic treatment.
The product will bring several benefits and improvements to radiotherapy processes:
1. Reduce the time needed to elaborate on a treatment plan by using Artificial Intelligence to detect tumors from CT and MRI scans. Time saved for the doctors translates into time saved for the patients.
2. Allow clinicians to communicate effectively by using a centralized platform and speeding up their work using our pipeline
3. Providing access to the treatment for a greater number of patients, by speeding up the process of radiotherapy.
4. Higher accuracy and objectivity in the tumor identification process.
The product guarantees quality, speed and accuracy. It would be beneficial both for the clinics that buy it (because of the cost reduction) and for the end-users (because of the complexity reduction). Moreover, the comprehensive product includes the “adaptive learning” and the “active revision” features that will bring big support to doctors using it. Adaptive Learning is a feature that is self-explanatory. The Neural Networks will learn from users' corrections and adaptations even after it is deployed. This will allow the AI to be perfectly accustomed to every doctor’s contouring guideline. Active Revision prompts the AI to assist any modifications doctors want to apply to the initial result.
The company is in process of applying for certification for the European space, - CE marking risk class 2a. CE marking serves the purpose of marketing medical devices freely in the EU, provided that the devices comply with any national requirements in force.
They will also assure the construction of system architecture, comprising of all the modules from ISO 13485, including IEC 62204 (software medical device), ISO 14971 (Risk Management) and ISO 27001(Cyber Security). As part of the process, a mandatory step is conducting a clinical study and to obtain clinical validation.
The Romanian entity is seeking partners - clinics and hospitals - that cover treatment with radiotherapy who are willing to test the software within their facilities.
Other potential partners could be medical distributors who can provide support on expanding to international markets. - Advantages and Innovations
-
The solution helps doctors identify and delineate cancerous tumors and organs at risk and is developed using Artificial Intelligence. This technology distinguishes itself from traditional technologies in healthcare through its ability to gather data, process it in a sophisticated manner and give a complex analysis to the end-user. Moreover, AI can process images and patient health records with more accuracy and expediency than humans are capable of, lessening physician workload, reducing misdiagnosis, and empowering clinical staff to provide more value.
The software satisfies a crucial need and it solves an important bottleneck within radiotherapy treatment planning.
The existing solutions on the market are helpful to radiation oncologists, but the important problem (the big amount of time needed for contouring) still remains. A doctor needs around 4 hours for the contouring/ delineation process per patient and the result is very subjective.
This software, based on AI, brings a huge difference. With the help of AI, tumor identification can be done in a fraction of time, with higher accuracy and objectivity. This will speed up the process, increasing the patient's survival rate. - Stage of Development
- Available for demonstration
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR status
- No IPR applied
Partner Sought
- Expected Role of a Partner
-
Seeking public and private radiotherapy centers interested in testing the automatic contouring software. The software is offered free of charge for the testing period of 6 months. After the 6 months, each contract will be discussed and there will be discounts for the certified software applied. The radiotherapy centers are encouraged to come with feedback and improvement advice during the testing period.
Moreover, the company is open to sign partnerships with radiotherapy clinics for projects and calls proposals applications, to further develop the solution.
The collaboration would be under the form of a Research and development cooperation agreement.
The company is also interested in a collaboration with medical equipment distributors who can facilitate the access to potential clients, under the form of a commercial agreement. - Type and Size of Partner
- SME <=10
- SME 50 - 249
- R&D Institution
- Other
- SME 11-49
- University
- Type of partnership
- Research and development cooperation agreement
Dissemination
- Technology keywords
- 01003003 - Artificial Intelligence (AI)
- 01003012 - Imaging, Image Processing, Pattern Recognition
- 01003006 - Computer Software
- 006001007 - Diseases
- 006001002 - Care and Health Services
- Market keywords
- 05007006 - Computer-aided diagnosis and therapy
- 005001002 - Medical imaging
- 02007016 - Artificial intelligence related software
- 02007012 - Medical/health software
- Sector Groups Involved
- Digital
- Health
- Targeted countries
- All countries
Files
AI-Based Contouring Software for Radiotherapy